Skip to main content
. 2012 Oct 2;7(1):32. doi: 10.1186/2049-6958-7-32

Table 3.

Factors associated with health-related quality of life: VAS scale (0 = worst health state, 100 = best health state); (n = 2034)

 
 
VAS score
  N Mean (SD) Adjusted mean differences (CI 95 %)*
Age
 
 
 
≥ 60 years
609
62.38 (17.46)
 
40 to 59 years
675
68.93 (16.66)
1.78 (−0.38,3.94)
18 to 39 years
750
76.34 (15.33)
4.99 (2.63,7.37)
Educational level
 
 
 
None
162
58.57 (18.52)
 
Primary
865
66.12 (17.18)
2.41 (−0.63,5.44)
Secondary
667
73.48 (16.02)
4.96 (1.64,8.28)
University
336
76.87 (14.92)
6.30 (2.69,9.90)
Asthma severity
 
 
 
Severe persistent
87
46.78 (17.21)
 
Moderate persistent
672
65.45 (16.86)
9.01 (5.07,12.96)
Mild persistent
754
72.97 (15.12)
11.40 (7.28,15.52)
Intermittent
520
74.26 (16.96)
9.49 (5.22,13.76)
Smoking habit
 
 
 
Current or former
753
68.47 (17.02)
 
Never
1,279
70.43 (17.58)
2.51 (1.13,3.89)
Stressful event last 15 days
 
 
 
Yes
296
61.47 (18.61)
 
No
1,731
71.10 (16.75)
6.17 (4.31,8.03)
Adherence is important (score, patient’s point of view):
 
 
 
< 8
511
65.25 (17.78)
 
≥ 8
1,521
71.23 (16.98)
4.02 (2.54,5.50)
ACQ score
 
 
 
>1.50
762
58.94 (16.38)
 
0.75-1.50
541
72.59 (13.89)
9.48 (7.53,11.44)
<0.75 731 78.79 (14.48) 13.26 (11.22,15.29)

Score of VAS scale, and probability of obtaining values greater than the mean on the VAS. Multivariate analysis.

*Adjusted by all the variables in the Table 1.

N, number of cases; VAS, Visual Analogue Scale; CI, Confidence interval; BMI, Body mass index; SABA, Short-acting beta2 agonists; LABA, Long-acting beta2 agonists; IC, Inhaled corticosteroids.